|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0008838,
umls-concept:C0015133,
umls-concept:C0022341,
umls-concept:C0205195,
umls-concept:C0205420,
umls-concept:C0282461,
umls-concept:C0684249,
umls-concept:C0817096,
umls-concept:C1274034,
umls-concept:C1274040,
umls-concept:C1518578,
umls-concept:C1522449,
umls-concept:C1705294,
umls-concept:C2603343
|
|
pubmed:issue |
14
|
|
pubmed:dateCreated |
2002-7-15
|
|
pubmed:abstractText |
To evaluate the optimal timing for thoracic radiotherapy (TRT) in limited-stage small-cell lung cancer (LS-SCLC), the Lung Cancer Study Group of the Japan Clinical Oncology Group conducted a phase III study in which patients were randomized to sequential TRT or concurrent TRT.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:FukudaHaruhikoH,
pubmed-author:FukuokaMasahiroM,
pubmed-author:KawaharaMasaakiM,
pubmed-author:NishiwakiYutakaY,
pubmed-author:NodaKazumasaK,
pubmed-author:SaijoNagahiroN,
pubmed-author:SugiuraTakahikoT,
pubmed-author:TakadaMinoruM,
pubmed-author:TamuraTomohideT,
pubmed-author:WatanabeKoshiroK,
pubmed-author:YokotaSoichiroS,
pubmed-author:YokoyamaAkiraA
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
3054-60
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:12118018-Adult,
pubmed-meshheading:12118018-Aged,
pubmed-meshheading:12118018-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12118018-Carcinoma, Small Cell,
pubmed-meshheading:12118018-Chemotherapy, Adjuvant,
pubmed-meshheading:12118018-Disease Progression,
pubmed-meshheading:12118018-Disease-Free Survival,
pubmed-meshheading:12118018-Drug Administration Schedule,
pubmed-meshheading:12118018-Female,
pubmed-meshheading:12118018-Humans,
pubmed-meshheading:12118018-Lung Neoplasms,
pubmed-meshheading:12118018-Male,
pubmed-meshheading:12118018-Middle Aged,
pubmed-meshheading:12118018-Prospective Studies,
pubmed-meshheading:12118018-Radiotherapy, Adjuvant,
pubmed-meshheading:12118018-Radiotherapy Dosage,
pubmed-meshheading:12118018-Risk,
pubmed-meshheading:12118018-Survival Analysis,
pubmed-meshheading:12118018-Treatment Outcome
|
|
pubmed:year |
2002
|
|
pubmed:articleTitle |
Phase III study of concurrent versus sequential thoracic radiotherapy in combination with cisplatin and etoposide for limited-stage small-cell lung cancer: results of the Japan Clinical Oncology Group Study 9104.
|
|
pubmed:affiliation |
Osaka Prefectural Habikino Hospital, Osaka City General Medical Center, Kinki National Hospital for Chest Disease, Osaka, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study,
Clinical Trial, Phase III
|
